Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,611 JPY | +3.82% | +5.18% | +20.69% |
Apr. 25 | Japan's life insurers edge up JGB purchase pace with yields expected to rise | RE |
Apr. 17 | Dai-ichi Life CEO expects unsolicited takeovers to become common practice in Japan | RE |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.44 for the 2024 fiscal year.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company does not generate enough profits, which is an alarming weak point.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+20.69% | 21.68B | B | ||
+6.49% | 50.92B | B+ | ||
+1.35% | 48.11B | B | ||
+9.53% | 42.2B | B+ | ||
+6.55% | 39.71B | B+ | ||
+19.34% | 37.78B | B | ||
+2.84% | 30.07B | B | ||
-7.77% | 27.56B | B- | ||
-18.42% | 24.71B | A- | ||
+6.89% | 21.99B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 8750 Stock
- Ratings Dai-ichi Life Holdings, Inc.